000 01608 a2200457 4500
005 20250513115031.0
264 0 _c19970424
008 199704s 0 0 eng d
022 _a0041-1345
024 7 _a10.1016/s0041-1345(96)00280-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFlorence, L S
245 0 0 _aReduction in the incidence of early rejection in cadaveric renal allograft recipients treated with ATGAM induction and sequential mycophenolate mofetil.
_h[electronic resource]
260 _bTransplantation proceedings
_c
300 _a313-4 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntilymphocyte Serum
_xtherapeutic use
650 0 4 _aAzathioprine
_xtherapeutic use
650 0 4 _aBiopsy
650 0 4 _aCadaver
650 0 4 _aFemale
650 0 4 _aGraft Rejection
_xepidemiology
650 0 4 _aHumans
650 0 4 _aImmunosuppression Therapy
_xmethods
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aIncidence
650 0 4 _aKidney Transplantation
_ximmunology
650 0 4 _aMale
650 0 4 _aMycophenolic Acid
_xanalogs & derivatives
650 0 4 _aTissue Donors
650 0 4 _aTransplantation, Homologous
700 1 _aHoward, D R
700 1 _aChapman, P H
700 1 _aLieberman, J
700 1 _aPerkinson, D T
700 1 _aMarks, W H
773 0 _tTransplantation proceedings
_gvol. 29
_gno. 1-2
_gp. 313-4
856 4 0 _uhttps://doi.org/10.1016/s0041-1345(96)00280-1
_zAvailable from publisher's website
999 _c9104541
_d9104541